State Street SPDR S&P Bio... (XBI)
NYSEArca: XBI
· Echtzeitkurs · USD
160.11
+0.58 (0.36%)
Zum Schluss: Aug 18, 2026, 3:59 PM
State Street SPDR S&P Biotech ETF (XBI) ETF Price, Holdings & Analysis
0.36% (1D)
| Geld | 0 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 9.63 Mrd |
| NAV | 159.47 |
| Beta | 1.14 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | k.A. |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Jan 31, 2006 |
| Brief | 160.6 |
| Volumen | 6,285,192 |
| Ø Vol. (20D) | 8,752,762 |
| Eröffnung | 158.34 |
| Vortagesschluss | 159.53 |
| Tagesspanne | 157.88 - 160.59 |
| 52-Wk Range | 88.18 - 165.71 |
| Positionen | k.A. |
| Kostenquote | 0.35% |
Über XBI
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Anlageklasse Equity
Tickersymbol XBI
Auflagedatum Jan 31, 2006
Anbieter State Street Investment Management
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 13.97% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.65% |
| Oruka Therapeutics I... | ORKA | 1.53% |
| Dianthus Therapeutic... | DNTH | 1.42% |
| Erasca Inc | ERAS | 1.38% |
| Twist Bioscience Cor... | TWST | 1.37% |
| Kymera Therapeutics ... | KYMR | 1.34% |
| Spyre Therapeutics I... | SYRE | 1.33% |
| Revolution Medicines... | RVMD | 1.32% |
| Cg Oncology Inc | CGON | 1.32% |
| Protagonist Therapeu... | PTGX | 1.31% |
Dividenden Dividendenrendite 0.36%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 22, 2026 | $0.1380 | k.A. |
| Dec 22, 2025 | $0.4070 | k.A. |
| Sep 22, 2025 | $0.0270 | k.A. |
| Jun 23, 2025 | $0.0070 | k.A. |
| Mar 24, 2025 | $0.0050 | k.A. |
Seite 1 von 2